BioVaxys Technology (BioVaxys Technology) YoY EBITDA Growth : 57.14% (As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BioVaxys Technology's YoY EBITDA Growth for the quarter that ended in Jul. 2023 was 57.14%.

BioVaxys Technology's EBITDA per Share for the three months ended in Jul. 2023 was $-0.00.

BioVaxys Technology YoY EBITDA Growth Historical Data

The historical data trend for BioVaxys Technology's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology YoY EBITDA Growth Chart

BioVaxys Technology Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

YoY EBITDA Growth

-81.25

-113.79

51.61

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
YoY EBITDA Growth	Get a 7-Day Free Trial															22.22	72.73	40.00	55.56	57.14

BioVaxys Technology YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BioVaxys Technology's YoY EBITDA Growth for the fiscal year that ended in Oct. 2022 is calculated as:

	YoY EBITDA Growth (A: Oct. 2022 )
=	(EBITDA per Share (A: Oct. 2022 )	-	EBITDA per Share (A: Oct. 2021 ))	/	\| EBITDA per Share (A: Oct. 2021 ) \|
=	(-0.03	-	-0.062)	/	\| -0.062 \|
=	51.61 %

BioVaxys Technology's YoY EBITDA Growth for the quarter that ended in Jul. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jul. 2023 )
=	(EBITDA per Share (Q: Jul. 2023 )	-	EBITDA per Share (Q: Jul. 2022 ))	/	\| EBITDA per Share (Q: Jul. 2022 )) \|
=	(-0.003	-	-0.007)	/	\| -0.007 \|
=	57.14 %

BioVaxys Technology YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

5LB:Germany BIOV:Canada

Address

146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4

Website

https://www.biovaxys.com

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.